Puma Biotechnology (PBYI) Change in Inventory (2017 - 2026)
Puma Biotechnology (PBYI) reported Change in Inventory of $3.2 million for Q1 2026, up 11670.37% on a YoY basis from N/an in Q1 2025, and up 180.23% quarter-over-quarter from -$4.0 million in Q4 2025.
Puma Biotechnology (PBYI) Change in Inventory (2017 - 2026) Analysis & Trends
Puma Biotechnology has reported Change in Inventory for 10 years, with the latest figure at $3.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 11670.37% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at -$58000.0 (down 103.51% YoY), and the FY2025 full-year result was -$3.2 million, down 295.19% from the prior year.
- Change in Inventory for Q1 2026 stood at $3.2 million, up from -$4.0 million in the prior quarter.
- The five-year high for Change in Inventory was $6.1 million in Q4 2024, with the low at -$6.4 million in Q3 2024.
- Historically, Change in Inventory has averaged $93176.5 across 5 years, with a median of $20000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 854.64% — and 2026, when it jumped 11670.37%.
- Puma Biotechnology's Change in Inventory stood at -$926000.0 in 2022, then jumped by 251.3% to $1.4 million in 2023, then jumped by 331.91% to $6.1 million in 2024, then plunged by 165.46% to -$4.0 million in 2025, then soared by 180.23% to $3.2 million in 2026.
- The last three Change in Inventory figures came in at $3.2 million (Q1 2026), -$4.0 million (Q4 2025), and $885000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | -3.96 Mn |
| Dec 31, 2025 | -3.96 Mn |
| Sep 30, 2025 | 885,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 6.05 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | -6.38 Mn |
| Sep 30, 2024 | -6.38 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |